Prelude Therapeutics Incorporated

Organization

Wilmington, DE, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 12,129,262
- Issue date Oct 29, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,939,340
- Issue date Mar 26, 2024
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BRM targeting compounds and associated methods of use
- Patent number 11,702,423
- Issue date Jul 18, 2023
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,685,744
- Issue date Jun 27, 2023
- Prelude Therapeutics Incorporated
- Andrew W. Buesking
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,673,893
- Issue date Jun 13, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein argi...
- Patent number 11,524,962
- Issue date Dec 13, 2022
- Prelude Therapeutics, Incorporated
- Juan Luengo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
- Patent number 11,254,683
- Issue date Feb 22, 2022
- Prelude Therapeutics Incorporated
- Juan Luengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
- Patent number 11,220,524
- Issue date Jan 11, 2022
- Prelude Therapeutics Incorporated
- Juan Luengo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
- Patent number 11,214,574
- Issue date Jan 4, 2022
- Prelude Therapeutics, Incorporated
- Juan Luengo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
- Patent number 11,208,416
- Issue date Dec 28, 2021
- Prelude Therapeutics Incorporated
- Hong Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemi...
- Patent number 11,130,769
- Issue date Sep 28, 2021
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)
- Patent number 11,078,205
- Issue date Aug 3, 2021
- Prelude Therapeutics, Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
- Patent number 10,711,007
- Issue date Jul 14, 2020
- Prelude Therapeutics Incorporated
- Juan Luengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
- Patent number 10,570,140
- Issue date Feb 25, 2020
- Prelude Therapeutics Incorporated
- Hong Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240352029
- Publication date Oct 24, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20240336612
- Publication date Oct 10, 2024
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240246993
- Publication date Jul 25, 2024
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM Targeting Compounds and Associated Methods of Use
- Publication number 20240190886
- Publication date Jun 13, 2024
- Prelude Therapeutics Incorporated
- Corey Howard Basch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20240165244
- Publication date May 23, 2024
- Prelude Therapeutics Incorporated
- Corey Howard Basch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240150340
- Publication date May 9, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS
- Publication number 20240124422
- Publication date Apr 18, 2024
- Prelude Therapeutics Incorporated
- Chun Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
- Publication number 20240018158
- Publication date Jan 18, 2024
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240018136
- Publication date Jan 18, 2024
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KAT6 TARGETING COMPOUNDS
- Publication number 20230416240
- Publication date Dec 28, 2023
- Prelude Therapeutics Incorporated
- Sarah Pawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20230365576
- Publication date Nov 16, 2023
- Prelude Therapeutics Incorporated
- John A. Rose
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMI...
- Publication number 20230357275
- Publication date Nov 9, 2023
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230357265
- Publication date Nov 9, 2023
- Prelude Therapeutics, Incorporated
- Andrew W. Buesking
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocycle CDK Inhibitors And Their Use Thereof
- Publication number 20230265083
- Publication date Aug 24, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230257394
- Publication date Aug 17, 2023
- Prelude Therapeutics, Incorporated
- Jincong ZHUO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230242543
- Publication date Aug 3, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230234964
- Publication date Jul 27, 2023
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEU...
- Publication number 20230212191
- Publication date Jul 6, 2023
- PRELUDE THERAPEUTICS, INCORPORATED
- Jincong ZHUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Argi...
- Publication number 20230174539
- Publication date Jun 8, 2023
- Prelude Therapeutics, Incorporated
- Hong LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230144528
- Publication date May 11, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20230083376
- Publication date Mar 16, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
- Publication number 20230029094
- Publication date Jan 26, 2023
- Prelude Therapeutics, Incorporated
- Ganfeng Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemi...
- Publication number 20230010358
- Publication date Jan 12, 2023
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20220324830
- Publication date Oct 13, 2022
- Prelude Therapeutics, Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20220267345
- Publication date Aug 25, 2022
- Prelude Therapeutics, Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes for Making PRMT5 Inhibitors
- Publication number 20220251088
- Publication date Aug 11, 2022
- Prelude Therapeutics, Incorporated
- Ganfeng Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
- Publication number 20220218732
- Publication date Jul 14, 2022
- Prelude Therapeutics, Incorporated
- Juan Luengo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)
- Publication number 20220177481
- Publication date Jun 9, 2022
- Prelude Therapeutics, Incorporated
- Juan Luengo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)
- Publication number 20220160713
- Publication date May 26, 2022
- Prelude Therapeutics, Incorporated
- Hong LIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
- Publication number 20220152072
- Publication date May 19, 2022
- Prelude Therapeutics, Incorporated
- Hong Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
88454877 - PRELUDE THERAPEUTICS
- Serial number 88454877
- Registration number 6918641
- Filing date May 31, 2019
- Prelude Therapeutics Incorporated
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88454849 - PRELUDE THERAPEUTICS
- Serial number 88454849
- Registration number 6918640
- Filing date May 31, 2019
- Prelude Therapeutics Incorporated
- 42 - Scientific and technological services and research and design relating thereto

Prelude Therapeutics Incorporated

Organization

Patents Grantslast 30 patents

CDK inhibitors and their use as pharmaceuticals

CDK inhibitors and their use as pharmaceuticals

BRM targeting compounds and associated methods of use

CDK inhibitors and their use as pharmaceuticals

CDK inhibitors and their use as pharmaceuticals

Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein argi...

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemi...

Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Patents Applicationslast 30 patents

CDK Inhibitors And Their Use As Pharmaceuticals

BRM Targeting Compounds And Associated Methods Of Use

CDK Inhibitors And Their Use As Pharmaceuticals

BRM Targeting Compounds and Associated Methods of Use

BRM Targeting Compounds And Associated Methods Of Use

CDK Inhibitors And Their Use As Pharmaceuticals

MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

CDK Inhibitors And Their Use As Pharmaceuticals

KAT6 TARGETING COMPOUNDS

BRM Targeting Compounds And Associated Methods Of Use

SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMI...

CDK Inhibitors And Their Use As Pharmaceuticals

Heterocycle CDK Inhibitors And Their Use Thereof

CDK Inhibitors And Their Use As Pharmaceuticals

CDK Inhibitors And Their Use As Pharmaceuticals

CDK Inhibitors And Their Use As Pharmaceuticals

SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEU...

Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Argi...

CDK Inhibitors And Their Use As Pharmaceuticals

BRM Targeting Compounds And Associated Methods Of Use

Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)

Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemi...

CDK Inhibitors And Their Use As Pharmaceuticals

CDK Inhibitors And Their Use As Pharmaceuticals

Processes for Making PRMT5 Inhibitors

Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)

SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)

SELECTIVE INHIBITOR OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)

Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)

Trademarklast 30 trademarks

88454877 - PRELUDE THERAPEUTICS

88454849 - PRELUDE THERAPEUTICS